Summary: Most of Dominic Lawson's comments on homeopathy (9 February) were spot-on, but he fails to understand the power of the placebo, which is far more complex than mere "gullibility". While it does seem immoral for companies to be making money from people's scientific ignorance, there is perhaps a case for maintaining the availability of such "treatments" on the NHS.
Title: Cara Therapeutics Reports Positive Phase II Data For Novel Peripheral Analgesic In Acute Post-Operative Pain
Summary: Cara Therapeutics, Inc. announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center, double-blind, placebo-controlled study was conducted at eight hospitals in the United States and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted hysterectomy. Subjects ...
Title: Crestor Approval Expanded For People Without High Cholesterol
Summary: TUESDAY, Feb. 9 (HealthDay News) -- U.S. Food and Drug Administration approval for Crestor (rosuvastatin) has been widened to include people who have no obvious symptoms of heart disease, Dow Jones reported.
Title: Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
Summary: Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. Â The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. Â The study will also evaluate ...
Title: Positive data from Cara Therapeutics' peripherally-restricted kappa opioid agonist Phase II trial
Summary: Cara Therapeutics, Inc. today announced positive data in a Phase II proof-of-concept clinical trial of its peripherally-restricted kappa opioid agonist, CR845. The 46 patient Phase II, multi-center, double-blind, placebo-controlled study was conducted at eight hospitals in the United States and evaluated the efficacy and safety of CR845 in women following laparoscopic-assisted hysterectomy.
Title: Pomegranate oil-seaweed mix may improve liver health and waist size
Summary: The new ingredient, marketed under the brand name Xanthigen, noted improvements in women with healthy livers and those suffering from non-alcoholic fatty liver disease (NAFLD), according to findings of a double-blind, randomised, placebo-controlled study with obese premenopausal women.
Title: Drug May Ease Cognitive Effects of Huntington's
Summary: TUESDAY, Feb. 9 (HealthDay News) -- An experimental drug may improve thinking, learning and memory skills in people with Huntington's disease, an inherited neurodegenerative disorder, new research says.
Summary: Uma revisão de onze estudos, envolvendo um total de 8.164 pessoas, publicada neste mês no periódico "Chest" mostra que o uso de corticoides inaláveis por pacientes com DPOC (doença pulmonar obstrutiva crônica) traz pouco resultado no controle de crises respiratórias em comparação com a ingestão de um placebo. As diretrizes internacionais sobre o tratamento da doença indicam o uso de corticoides ...
